Even though some quantitative results, such as E-Cadherin in U87 cells, showed no difference (Fig. 4c and d), we could also draw the conclusion that Smarcd1 inhibited the ability of invasion in glioma cells by combination of the transwell assays and the protein expression tendency. Here, SMARCD1 is linked to central nervous system cancer.